Professor of Stroke Medicine
- Chief Executive Officer, Oxford Academic Health Science Network
- Consultant Stroke Physician OUH
My work focuses on developing and evaluating treatments that can reduce brain damage in the first few hours after stroke, and developing better processes of care to deliver for stroke patients.
I have developed and evaluated the performance of stroke recognition instruments such as the Face Arm Speech Test (FAST) and Recognition of Stroke in the Emergency Room Scale (ROSIER) to improve early diagnosis of stroke by the public, ambulance paramedics and Emergency Department teams.
My work has evaluated the risks and benefits of thrombolysis in very elderly stroke patients 80 years or older, who are the population at highest risk of stroke.
In addition to my research in stroke my work more broadly seeks to understand the risks and benefits of drug therapies in older people.
Complications of endovascular treatment for acute ischemic stroke: Prevention and management.
Balami JS. et al, (2018), Int J Stroke, 13, 348 - 361
Advances in Stroke 2017.
Bernhardt J. et al, (2018), Stroke, 49, e174 - e199
Progress toward standardized diagnosis of vascular cognitive impairment: Guidelines from the Vascular Impairment of Cognition Classification Consensus Study.
Skrobot OA. et al, (2018), Alzheimers Dement, 14, 280 - 292
European Academy of Neurology and European Stroke Organization consensus statement and practical guidance for pre-hospital management of stroke.
Kobayashi A. et al, (2018), Eur J Neurol, 25, 425 - 433
Factors that influence clinicians’ decisions to offer intravenous alteplase in acute ischemic stroke patients with uncertain treatment indication: Results of a discrete choice experiment
De Brún A. et al, (2018), International Journal of Stroke, 13, 74 - 82